Hypocomplementary urticarial vasculitis (HUV) is a complex and rare disorder characterized by vascular inflammation leading to skin damage and organ involvement. The disease is usually classified as a systemic vasculitide and is named for the decreased serum complement levels, suggesting an autoimmune process. HUV is most commonly seen in middle-aged women, but can occur at any age. The clinical course can range from a mild skin rash to severe, life-threatening organ involvement.
History of the disease and interesting historical facts
The history of Hypocomplementary urticarial vasculitis is interesting because the disease itself was first described only in the late 20th century, when the medical community began to more actively study various forms of vasculitis. Some medical researchers note that early signs of the disease could be misdiagnosed as other forms of dermatological diseases. In the early 2000s, with the development of modern laboratory diagnostic methods, including serological tests for determining the level of complement and specific antibodies, it became possible to more accurately identify HUKV. It is also interesting that HUKV is often associated with other autoimmune diseases, such as systemic lupus erythematosus and Sjogren's syndrome, which suggests the presence of a common pathogenetic mechanism between them.
Epidemiology
Hypocomplementary urticarial vasculitis is a rare disease, its prevalence in the population is approximately 1-3 cases per 100,000 people. In most cases, the disease is diagnosed in women aged 30 to 50 years. However, there is a fairly high variability in different regions and among different ethnic groups. According to several clinical studies, the frequency of comorbidities associated with HCV, as well as the risk of relapse, is significantly increased in the presence of other chronic diseases.
Genetic predisposition to this disease
According to modern data, there is a genetic predisposition to the development of hypocomplementary urticarial vasculitis. It has been established that the characteristics of genes responsible for the immune response and complement regulation may play a certain role in the development of the disease. In particular, mutations in genes such as C4, C5 and others increase the risk of poor functioning of the complement system, which may contribute to the manifestation of the autoimmune process. Despite this, the study of genetic factors is still in its early stages.
Risk factors for the development of this disease
Risk factors that contribute to the development of hypocomplementary urticarial vasculitis include:
- History of autoimmune diseases – the presence of other autoimmune processes in the patient can significantly increase the risk of GBC.
- Infectious diseases – certain infectious agents (eg, hepatitis viruses) can serve as triggers for vasculitis.
- Chemical exposure – Working with toxic chemicals, including solvents and pesticides, may increase your risk.
- Genetic predisposition – the presence of data on relatives with similar diseases.
- Gender and age – this vasculitis is more common in older women.
Diagnosis of this disease
Diagnosis of hypocomplementary urticarial vasculitis includes clinical and laboratory studies. The main symptoms of the disease are:
- Skin rash (petechiae, purpura, urticaria)
- Pain and swelling in the joints
- Systemic manifestations (fever, fatigue)
Laboratory tests should include:
- A complete blood count to assess the status of blood transfusion and the presence of inflammatory changes.
- Biochemical blood test for complement levels and specific antibodies (activated complement, antibodies to nuclear antigens).
Radiological examinations such as ultrasound or CT may be helpful in assessing the status of the organs involved (eg, kidneys and lungs). Differential diagnosis should include other forms of vasculitis and dermatoses.
Treatment
The mainstay of treatment for hypocomplementary urticarial vasculitis involves a combination of pharmacological and non-pharmacological methods.
General treatment:
- Lifestyle changes, including diet and physical activity.
- Psychosocial support.
Pharmacological treatment may include:
- Corticosteroids to control inflammation.
- Immunosuppressants (eg, cyclophosphamide, azathioprine).
Surgical treatment may be necessary in cases of severe organ damage requiring intervention (for example, on the kidneys). Plasmapheresis is also used in cases of severe relapses.
List of medications used to treat this disease
- Prednisolone
- Cyclophosphamide
- Methotrexate
- Azathioprine
- Rituximab
- Plasmapheresis
Disease monitoring
Effective patient monitoring includes regular follow-up examinations to assess disease dynamics and treatment effectiveness. The prognosis for patients with Hypocomplementary Urticarial Vasculitis may vary:
- With early diagnosis and adequate treatment, most patients have a favorable prognosis.
- However, some may experience long-term relapses and complications (eg, organ damage, lack of blood supply).
Age-related features of the disease
Hypocomplementary urticarial vasculitis may present differently depending on the patient's age. In older people, clinical manifestations may be less obvious and may be masked by other diseases, while in younger people, a more aggressive course of the disease may be observed. In children, HCV is more often found with systemic manifestations, requiring constant monitoring and treatment to prevent complications.
Questions and Answers
- What are the main symptoms of hypocomplementary urticarial vasculitis? Symptoms include skin rash, joint pain, and systemic manifestations such as fever and fatigue.
- What causes this disease? The underlying cause is unknown, but predisposing factors include autoimmune diseases and chemical exposures.
- How is GKV diagnosed? Diagnosis includes clinical examination, laboratory tests and, if necessary, radiological methods.
- What is the most effective treatment for GBC? Effective treatment includes corticosteroids, immunosuppressants and pathogenetic therapy.
- What is the duration of treatment for GKV? The duration of treatment varies depending on the severity of the disease and response to therapy, but long-term monitoring is recommended.
Advice from Dr. Oleg Korzhikov
Priority aspects in the management of hypocomplementary urticarial vasculitis are:
- Regular visits to the doctor to monitor your health.
- Keeping a symptom diary to help identify triggers for worsening symptoms.
- Discussing lifestyle changes, such as diet, with your doctor to support improvement of your overall health.
- Taking medications strictly as prescribed and following recommended dosages.
- Seek psychosocial support if needed.
Following these recommendations will help achieve positive results in treatment and improve the quality of life of patients.
